Glyburide Tablet
Product Images NDC 65841-833

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glyburide (NDC 65841-833). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (B5a1c773 00b7 4673 9cd9 1b52d6528bb8 01)

FDA Label Image

Figure (B5a1c773 00b7 4673 9cd9 1b52d6528bb8 02)

Figure (B5a1c773 00b7 4673 9cd9 1b52d6528bb8 02)
This is a description of a medication called Glyburide, which is a tablet used for prescription purposes only. The medication is manufactured by Catla Healthcare Ltd in Badd, India, and is in a bottle of 100 tablets. The usual dosage is available in the package insert, and each tablet contains 125mg of Glyburide USP. The tablets should be stored at a controlled room temperature of 20° to 25° C and kept out of reach of children.*
FDA Label Image

Figure (B5a1c773 00b7 4673 9cd9 1b52d6528bb8 03)

Figure (B5a1c773 00b7 4673 9cd9 1b52d6528bb8 03)
NDC 65841-833-01 is a prescription drug called GlyBURIDE, supplied by Cartla Healthcare L. The drug is in tablet form, with each containing 25mg of Gyburide, USP. A usual dosage is indicated in the package insert. It is recommended to store the drug in a tight container and at a temperature of 20-25°C (68-77°F). This drug should be kept out of the reach of children. Rev: 00100.*
FDA Label Image

Figure (B5a1c773 00b7 4673 9cd9 1b52d6528bb8 04)

Figure (B5a1c773 00b7 4673 9cd9 1b52d6528bb8 04)
This is a description of Glyburide, a prescription medication in tablet form used to treat type 2 diabetes. Each tablet contains 5mg of the active ingredient, Gyburide USP. The instructions for use are detailed in the package insert, and the medication should be stored at room temperature. This medication should be kept out of reach of children. The manufacturer is listed as Catla Healthcare Ltd, located in Badd, India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.